Duration and intensity of anticoagulation among patients with genetic predispositions to venous thrombosis.
Ridker
P M
PM
Divisions of Cardiovascular Diseases and Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
D000925:Anticoagulants / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D018570:Risk Assessment; D013997:Time Factors; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000235:genetics; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; D014859:Warfarin